FENTANYL CITRATE
Substance profile for UNII MUN5LYG46H, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.
Structure render from PubChem CID 13810Substance Identity#
- UNII
- MUN5LYG46H
- Preferred term
- FENTANYL CITRATE
- Registry number
- 990-73-8
- EC number
- 213-588-0
- Ingredient type
- INGREDIENT SUBSTANCE
- Molecular formula
- C22H28N2O.C6H8O7
Structure render from PubChem CID 13810Chemical And Database Identifiers#
- InChIKey
- IVLVTNPOHDFFCJ-UHFFFAOYSA-N
- SMILES
- OC(=O)CC(O)(CC(O)=O)C(O)=O.CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1)C3=CC=CC=C3
- RxCUI
- 142436
- PubChem
- 13810
- NCIt
- C47994
- INN ID
- 0
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| FENTANYL CITRATE | ACTIVE INGREDIENT | MUN5LYG46H | Fentanyl Citrate 1 mcg/mL & Bupivacaine HCl 0.125% in 0.9% Sodium Chloride 100 mL Bag | 6 | |
| Fentanyl Citrate | ACTIVE INGREDIENT | MUN5LYG46H | Fentanyl Citrate 2 mcg/mL & Bupivacaine HCl 0.125% in 0.9% Sodium Chloride 100 mL Bag | 5 | |
| Fentanyl Citrate | ACTIVE INGREDIENT | MUN5LYG46H | Fentanyl Citrate 2 mcg/mL & Bupivacaine HCl 0.125% in 0.9% Sodium Chloride 125 mL Bag | 2 | |
| fentanyl citrate | ACTIVE INGREDIENT | MUN5LYG46H | These highlights do not include all the information needed to use ABSTRAL safely and effectively. See full prescribing information for ABSTRAL. ABSTRAL ® (fentanyl) sublingual tablets CII Initial U.S. Approval: 1968 | 2 | |
| Fentanyl Citrate | ACTIVE INGREDIENT | MUN5LYG46H | Fentanyl Citrate 2 mcg/mL & Bupivacaine HCl 0.125% in 0.9% Sodium Chloride 250 mL Bag | 8 | |
| FENTANYL CITRATE | ACTIVE INGREDIENT | MUN5LYG46H | Fentanyl Citrate 5 mcg/mL in 0.9% Sodium Chloride 3 mL Syringe | 4 | |
| Fentanyl Citrate | ACTIVE INGREDIENT | MUN5LYG46H | Fentanyl Citrate 2 mcg/mL & Bupivacaine HCl 0.125% in 0.9% Sodium Chloride 250 mL Bag | 3 | |
| Fentanyl Citrate | ACTIVE INGREDIENT | MUN5LYG46H | Fentanyl Citrate 3 mcg/mL & Bupivacaine HCl 0.125% in 0.9% Sodium Chloride 200 mL Bag | 5 | |
| FENTANYL CITRATE | ACTIVE INGREDIENT | MUN5LYG46H | Fentanyl Citrate 20 mcg/mL in 0.9% Sodium Chloride 30 mL PCA Vial, Non-MedNet | 1 | |
| Fentanyl Citrate | ACTIVE INGREDIENT | MUN5LYG46H | Fentanyl Citrate 50 mcg/mL in Sterile Water 2 mL Syringe | 5 | |
| Fentanyl Citrate | ACTIVE INGREDIENT | MUN5LYG46H | Fentanyl Citrate 50 mcg/mL in Sterile Water 5 mL Syringe | 5 | |
| Fentanyl Citrate | ACTIVE INGREDIENT | MUN5LYG46H | Fentanyl Citrate 50 mcg/mL in Sterile Water 20 mL Syringe | 6 | |
| Fentanyl Citrate | ACTIVE INGREDIENT | MUN5LYG46H | Fentanyl Citrate 20 mcg/mL in 0.9% Sodium Chloride 100 mL Bag | 3 | |
| FENTANYL CITRATE | ACTIVE INGREDIENT | MUN5LYG46H | Fentanyl Citrate 20 mcg/mL in 0.9% Sodium Chloride 30 mL PCA Vial | 1 | |
| Fentanyl Citrate | ACTIVE INGREDIENT | MUN5LYG46H | These highlights do not include all the information needed to use LAZANDA safely and effectively. See full prescribing information for LAZANDA Lazanda ® (Fentanyl) Nasal Spray CII Initial U.S. Approval: 1968 | 5 | |
| FENTANYL CITRATE | ACTIVE INGREDIENT | MUN5LYG46H | These highlights do not include all the information needed to use ABSTRAL safely and effectively. See full prescribing information for ABSTRAL. ABSTRAL ® (fentanyl) sublingual tablets CII Initial U.S. Approval: 1968 | 3 | |
| FENTANYL CITRATE | ACTIVE INGREDIENT | MUN5LYG46H | These highlights do not include all the information needed to use Oral Transmucosal Fentanyl Citrate (OTFC) safely and effectively. See full prescribing information for OTFC. Oral Transmucosal Fentanyl Citrate (OTFC) (fentanyl citrate) oral transmucosal lozenge, CII Initial U.S. Approval: 1968 | 1 | |
| FENTANYL CITRATE | ACTIVE INGREDIENT | MUN5LYG46H | These highlights do not include all the information needed to use Oral Transmucosal Fentanyl Citrate (OTFC) safely and effectively. See full prescribing information for OTFC. Oral Transmucosal Fentanyl Citrate (OTFC) (fentanyl citrate) oral transmucosal lozenge, CII Initial U.S. Approval: 1968 | 2 | |
| fentanyl citrate | ACTIVE INGREDIENT | MUN5LYG46H | SUBLIMAZE ® Injection CII | 1 | |
| FENTANYL CITRATE | ACTIVE INGREDIENT | MUN5LYG46H | FENTANYL CITRATE INJECTION, SOLUTION [HOSPIRA, INC.] | 16 | |
| FENTANYL CITRATE | ACTIVE INGREDIENT | MUN5LYG46H | FENTANYL CITRATE LOZENGE [CIMA LABS INC.] | 12 | |
| FENTANYL CITRATE | ACTIVE INGREDIENT | MUN5LYG46H | FENTANYL CITRATE (FENTANYL CITRATE ) LOZENGE [MALLINCKRODT INC.] | 11 | |
| FENTANYL CITRATE | ACTIVE INGREDIENT | MUN5LYG46H | FENTANYL CITRATE INJECTION, SOLUTION [HOSPIRA, INC.] | 11 | |
| FENTANYL CITRATE | ACTIVE INGREDIENT | MUN5LYG46H | FENTORA (FENTANYL CITRATE) TABLET [CEPHALON, INC.] | 10 | |
| FENTANYL CITRATE | ACTIVE INGREDIENT | MUN5LYG46H | ACTIQ (FENTANYL CITRATE) LOZENGE [CEPHALON, INC.] | 7 | |
| FENTANYL CITRATE | ACTIVE INGREDIENT | MUN5LYG46H | FENTANYL CITRATE INJECTION, SOLUTION [CANTRELL DRUG COMPANY] | 7 | |
| FENTANYL CITRATE | ACTIVE INGREDIENT | MUN5LYG46H | FENTANYL CITRATE INJECTION, SOLUTION [CANTRELL DRUG COMPANY] | 6 | |
| FENTANYL CITRATE | ACTIVE INGREDIENT | MUN5LYG46H | FENTANYL BUCCAL TABLET [WATSON LABORATORIES, INC.] | 5 | |
| FENTANYL CITRATE | ACTIVE INGREDIENT | MUN5LYG46H | FENTANYL CITRATE INJECTION, SOLUTION [CANTRELL DRUG COMPANY] | 5 | |
| FENTANYL CITRATE | ACTIVE INGREDIENT | MUN5LYG46H | FENTANYL CITRATE INJECTION, SOLUTION [CANTRELL DRUG COMPANY] | 5 | |
| FENTANYL CITRATE | ACTIVE INGREDIENT | MUN5LYG46H | FENTANYL CITRATE INJECTION, SOLUTION [CANTRELL DRUG COMPANY] | 5 | |
| FENTANYL CITRATE | ACTIVE INGREDIENT | MUN5LYG46H | FENTANYL CITRATE INJECTION, SOLUTION [CANTRELL DRUG COMPANY] | 4 | |
| FENTANYL CITRATE | ACTIVE INGREDIENT | MUN5LYG46H | FENTANYL CITRATE INJECTION, SOLUTION [CANTRELL DRUG COMPANY] | 4 | |
| FENTANYL CITRATE | ACTIVE INGREDIENT | MUN5LYG46H | FENTANYL CITRATE INJECTION, SOLUTION [CANTRELL DRUG COMPANY] | 4 | |
| FENTANYL CITRATE | ACTIVE INGREDIENT | MUN5LYG46H | FENTANYL CITRATE INJECTION, SOLUTION [CANTRELL DRUG COMPANY] | 4 | |
| Fentanyl Citrate | ACTIVE INGREDIENT | MUN5LYG46H | FENTANYL CITRATE INJECTION, SOLUTION [CANTRELL DRUG COMPANY] | 4 | |
| FENTANYL CITRATE | ACTIVE INGREDIENT | MUN5LYG46H | FENTANYL CITRATE LOZENGE [PAR PHARMACEUTICAL INC.] | 4 | |
| FENTANYL CITRATE | ACTIVE INGREDIENT | MUN5LYG46H | FENTANYL CITRATE INJECTION [AKORN, INC.] | 3 | |
| FENTANYL CITRATE | ACTIVE INGREDIENT | MUN5LYG46H | FENTANYL CITRATE INJECTION, SOLUTION [BAXTER HEALTHCARE CORPORATION] | 3 | |
| Fentanyl Citrate | ACTIVE INGREDIENT | MUN5LYG46H | FENTANYL CITRATE INJECTION, SOLUTION [CANTRELL DRUG COMPANY] | 3 | |
| Fentanyl Citrate | ACTIVE INGREDIENT | MUN5LYG46H | FENTANYL CITRATE INJECTION, SOLUTION [CANTRELL DRUG COMPANY] | 3 | |
| Fentanyl Citrate | ACTIVE INGREDIENT | MUN5LYG46H | FENTANYL CITRATE, BUPIVACAINE HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY] | 3 | |
| Fentanyl Citrate | ACTIVE INGREDIENT | MUN5LYG46H | FENTANYL CITRATE, BUPIVACAINE HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY] | 3 | |
| FENTANYL CITRATE | ACTIVE INGREDIENT | MUN5LYG46H | LAZANDA (FENTANYL CITRATE) SPRAY [DEPOMED, INC.] | 3 | |
| FENTANYL CITRATE | ACTIVE INGREDIENT | MUN5LYG46H | FENTANYL CITRATE INJECTION, SOLUTION [CANTRELL DRUG COMPANY] | 2 | |
| Fentanyl Citrate | ACTIVE INGREDIENT | MUN5LYG46H | FENTANYL CITRATE, BUPIVACAINE HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY] | 2 | |
| Fentanyl Citrate | ACTIVE INGREDIENT | MUN5LYG46H | FENTANYL CITRATE, BUPIVACAINE HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY] | 2 | |
| FENTANYL CITRATE | ACTIVE INGREDIENT | MUN5LYG46H | FENTANYL CITRATE INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 1 | |
| FENTANYL CITRATE | ACTIVE INGREDIENT | MUN5LYG46H | FENTANYL CITRATE INJECTION, SOLUTION [CANTRELL DRUG COMPANY] | 1 | |
| FENTANYL CITRATE | ACTIVE INGREDIENT | MUN5LYG46H | FENTANYL CITRATE INJECTION, SOLUTION [CANTRELL DRUG COMPANY] | 1 | |
| FENTANYL CITRATE | ACTIVE INGREDIENT | MUN5LYG46H | FENTANYL CITRATE INJECTION, SOLUTION [CANTRELL DRUG COMPANY] | 1 | |
| FENTANYL CITRATE | ACTIVE INGREDIENT | MUN5LYG46H | FENTANYL CITRATE INJECTION, SOLUTION [CANTRELL DRUG COMPANY] | 1 | |
| FENTANYL CITRATE | ACTIVE INGREDIENT | MUN5LYG46H | FENTANYL CITRATE INJECTION, SOLUTION [CANTRELL DRUG COMPANY] | 1 | |
| Fentanyl Citrate | ACTIVE INGREDIENT | MUN5LYG46H | FENTANYL CITRATE INJECTION, SOLUTION [CANTRELL DRUG COMPANY] | 1 | |
| FENTANYL CITRATE | ACTIVE INGREDIENT | MUN5LYG46H | FENTANYL CITRATE LOZENGE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC] | 1 | |
| FENTANYL CITRATE | ACTIVE INGREDIENT | MUN5LYG46H | FENTANYL CITRATE LOZENGE [TEVA PHARMACEUTICALS USA INC] | 1 | |